Perspective of Dutch Patients with Gout on Continuation or Discontinuation of Urate‐Lowering Therapy During Remission: A Mixed‐Methods Study
Authors' conclusion
These results can aid shared decision-making and provide input for what is important to discuss with patients with gout in remission when they consider ULT discontinuation.
Study context
- Population
- Dutch patients with gout in remission on urate-lowering therapy (ULT)Substudy 1: 18
- Outcome
- Factors influencing the decision for continuation or discontinuation of ULT and their relative importance (rescaled probability score)
Methodological detailssemistructured interviews with inductive thematic analysis, maximum difference scaling
- Semistructured interviews with inductive thematic analysis
- Maximum difference scaling
Main finding
As reported in the abstract
Relative importance of items for ULT (dis)continuation
Items identified in substudy 1
22 items within 10 overarching themes
Original publication
Perspective of Dutch Patients with Gout on Continuation or Discontinuation of Urate‐Lowering Therapy During Remission: A Mixed‐Methods Study. Arthritis Care Res (Hoboken). Published 23 July 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →